Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Split-dose vs Full-dose PEG for Adenoma Detection
NCT02178033Unknown
- Sponsor
- Valduce Hospital
- Start
- Jan 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of macrogol in Colonic adenoma (2 arms), sponsored by Valduce Hospital. Primary endpoint: Adenoma Detection Rate at 1 year. Status: unknown.
02
Drugs
macrogol
03
Conditions
Colonic adenoma
Beyond the preview
Go deeper on NCT02178033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02178033.